• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)

    2/14/23 12:08:38 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $MURF alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A MMCAP International Inc. SPC: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)

    Murphy Canyon Acquisition Corp.

    (Name of Issuer)


    Class A Common Stock, par value $0.0001

    (Title of Class of Securities)


    626642102

    (CUSIP Number)


    December 31, 2022

    (Date of Event Which Requires Filing of This Statement)

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)


    CUSIP No. 626642102

     

    Page 2 of 7 Pages


    1

    NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

       
      MMCAP International Inc. SPC    
           
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a) ☑
    (b) ☐
               
               
    3 SEC USE ONLY    
               
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Cayman Islands    
           
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5 SOLE VOTING POWER    
      0    
    6 SHARED VOTING POWER    
      350,000*    
    7 SOLE DISPOSITIVE POWER    
      0    
    8 SHARED DISPOSITIVE POWER    
      350,000*    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      350,000*
       
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*   ☐
       
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
      2.50%**
       
    12 TYPE OF REPORTING PERSON
      CO
       

    FOOTNOTES

    * Consist of 350,000 shares of the Issuer’s Class A common stock.

    ** The percentages used herein are calculated based on 13,979,000 shares outstanding of the Issuer as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2022.


    CUSIP No. 626642102

     

    Page 3 of 7 Pages


    1

    NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

       
      MM Asset Management Inc.    
           
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a) ☑
    (b) ☐
               
               
    3 SEC USE ONLY    
               
               
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
      Ontario, Canada    
           
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5 SOLE VOTING POWER    
      0    
    6 SHARED VOTING POWER    
      350,000*    
    7 SOLE DISPOSITIVE POWER    
      0    
    8 SHARED DISPOSITIVE POWER    
      350,000*    
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      350,000*
       
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*   ☐
       
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
      2.50%**
       
    12 TYPE OF REPORTING PERSON
      CO
       

    FOOTNOTES

    * Consist of 350,000 shares of the Issuer’s Class A common stock.

    ** The percentages used herein are calculated based on 13,979,000 shares outstanding of the Issuer as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2022.


    CUSIP No. 626642102

     

    Page 4 of 7 Pages

    Item 1 (a). Name of Issuer:

    Murphy Canyon Acquisition Corp.

    Item 1 (b). Address of Issuer's Principal Executive Offices:

    4995 Murphy Canyon Road, Suite 300, San Diego 92123

    Item 2 (a). Name of Person Filing:

    i) MMCAP International Inc. SPC

    ii) MM Asset Management Inc.

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

    i) c/o Mourant Governance Services (Cayman) Limited
    94 Solaris Avenue
    Camana Bay, P.O. Box 1348
    Grand Cayman, KY1-1108, Cayman Islands

    ii) 161 Bay Street
    TD Canada Trust Tower Suite 2240
    Toronto, ON M5J 2S1 Canada

    Item 2 (c). Citizenship:

    i) Cayman Islands
    ii) Ontario, Canada

    Item 2 (d). Title of Class of Securities:

    Class A Common Stock, par value $0.0001

    Item 2 (e). CUSIP Number:

    626642102

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     (a) ☐ Broker or dealer registered under Section 15 of the Act;

     (b) ☐ Bank as defined in Section 3(a)(6) of the Act;

     (c) ☐ Insurance Company as defined in Section 3(a)(19) of the Act;

     (d) ☐ Investment Company registered under Section 8 of the Investment Company Act;

     (e) ☐ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f) ☐ Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);

     (g) ☐ Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);

     (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;


    CUSIP No. 626642102

     

    Page 5 of 7 Pages

     (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:

     (j) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

     ☒ If this statement is filed pursuant to Rule 13d-1(c), check this box.

    Item 4. Ownership.

     Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

     (a) Amount beneficially owned: 0

     (b) Percent of class:  2.50%**

     (c) Number of shares as to which such person has:

     (i) Sole power to vote or to direct the vote:  0

     (ii) Shared power to vote or to direct the vote:  350,000*

     (iii) Sole power to dispose or to direct the disposition of:  0

     (iv) Shared power to dispose or to direct the disposition of: 350,000*

    * Consist of 350,000 shares of the Issuer's Class A common stock.

    ** The percentages used herein are calculated based on 13,979,000 shares outstanding of the Issuer as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2022.

    Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

    Item 5. Ownership of Five Percent or Less of a Class.

     If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ].

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     N/A

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     N/A

    Item 8. Identification and Classification of Members of the Group.

     N/A

    Item 9. Notice of Dissolution of Group.

     N/A


    CUSIP No. 626642102

     

    Page 6 of 7 Pages

    Item 10. Certification.  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    MMCAP International Inc. SPC

     

     

    Date: February 14, 2023

    By: /s/ Ulla Vestergaard                         

       

     

        Name: Ulla Vestergaard

        Title: Director

     

     

     

     

     

     

     

    MM Asset Management Inc.

     

     

    Date: February 14, 2023

    By: /s/ Hillel Meltz                                      

       

     

        Name: Hillel Meltz

        Title: President



    CUSIP No. 626642102

     

    Page 7 of 7 Pages

    EXHIBIT 1

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

    Dated: February 14, 2023

     

    MMCAP International Inc. SPC

     

     

     

    By: /s/ Ulla Vestergaard                         

       

     

        Name: Ulla Vestergaard

        Title: Director

     

     

     

     

     

     

     

    MM Asset Management Inc.

     

     

     

    By: /s/ Hillel Meltz                                      

       

     

        Name: Hillel Meltz

        Title: President



    Get the next $MURF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MURF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MURF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Lewis-Hall Freda C

    4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)

    12/14/23 5:16:03 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Mcnealey Jennifer Isacoff

    4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)

    12/5/23 5:20:25 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Bligh James

    4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)

    12/5/23 5:20:29 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MURF
    SEC Filings

    View All

    SEC Form S-8 filed by Murphy Canyon Acquisition Corp.

    S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)

    1/10/24 4:43:04 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Murphy Canyon Acquisition Corp.

    424B3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)

    12/18/23 4:14:52 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Murphy Canyon Acquisition Corp.

    EFFECT - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)

    12/18/23 12:15:16 AM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MURF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

    SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose acquisition company (NASDAQ:MURF) ("MURF"), announced today the completion of the previously announced business combination (the "Transaction"). Conduit expects to commence trading on September 25, 2023, under ticker symbol "CDT" for its common stock on The Nasdaq Global Market and ticker symbol "CDTTW" for its warrants on The Nasdaq Capital Market.At the debut of trading, there will be a pro forma enterpris

    9/22/23 9:01:00 AM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited

    SAN DIEGO, CA / ACCESSWIRE / September 20, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) ("MURF" or "Murphy Canyon"), a special purpose acquisition company, announced today that at a special meeting of the MURF stockholders (the "Special Meeting") held today, MURF's stockholders voted in favor of the proposed business combination (the "Business Combination") with Conduit Pharmaceuticals Limited ("Conduit") and the related proposals. As a result, the completion of the Business Combination is expected to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions. Following the completion of the Business Combination, the newly combined company wil

    9/20/23 5:40:00 PM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives

    SAN DIEGO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (NASDAQ:SQFT, SQFTP))) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors (the "Board") has established a Special Committee of the Board (the "Special Committee") to explore potential strategic alternatives focusing on maximizing stockholder value. The Special Committee is comprised solely of independent directors and is charged with exploring potential strategic alternatives, including, without limitation, a business combination involving the Company, a sale of all or part of the Company's assets, joint venture arrangements and/or

    9/13/23 8:30:00 AM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    $MURF
    Financials

    Live finance-specific insights

    View All

    Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

    SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose acquisition company (NASDAQ:MURF) ("MURF"), announced today the completion of the previously announced business combination (the "Transaction"). Conduit expects to commence trading on September 25, 2023, under ticker symbol "CDT" for its common stock on The Nasdaq Global Market and ticker symbol "CDTTW" for its warrants on The Nasdaq Capital Market.At the debut of trading, there will be a pro forma enterpris

    9/22/23 9:01:00 AM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited

    SAN DIEGO, CA / ACCESSWIRE / September 20, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) ("MURF" or "Murphy Canyon"), a special purpose acquisition company, announced today that at a special meeting of the MURF stockholders (the "Special Meeting") held today, MURF's stockholders voted in favor of the proposed business combination (the "Business Combination") with Conduit Pharmaceuticals Limited ("Conduit") and the related proposals. As a result, the completion of the Business Combination is expected to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions. Following the completion of the Business Combination, the newly combined company wil

    9/20/23 5:40:00 PM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended June 30, 2023

    SAN DIEGO, CA / ACCESSWIRE / August 14, 2023 / Presidio Property Trust, Inc. (NASDAQ:SQFT)(NASDAQ:SQFTP) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its quarter ended June 30, 2023.Quarter Ended June 30, 2023, Financial ResultsNet loss attributable to the Company's common stockholders for the three months ended June 30, 2023, was approximately $1,831,889, or $(0.15) per basic and diluted share, compared to a net loss of approximately $830,212, or $(0.07) per basic and diluted share for the three months ended June 30, 2022. The change in net income attributable to the Company's common stockholders was a result of: •An

    8/14/23 5:30:00 PM ET
    $MURF
    $SQFT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    $MURF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)

    SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)

    2/12/24 12:51:14 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)

    SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)

    2/8/24 1:15:17 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)

    SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)

    2/2/24 4:28:59 PM ET
    $MURF
    Biotechnology: Pharmaceutical Preparations
    Health Care